Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

NCT00882193 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped new medications with improved response released

Conditions

Chronic Hepatitis C
Genotype 1
Relapse

Interventions

DRUG: Betaine
DRUG: Peginterferon alpha 2a
DRUG: Ribavirin

Sponsor

University of Nebraska